Health Care · Pharmaceutical Preparations · OTC · CIK 1815974 · FYE Jun 30 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.33Day +0.00%Mkt cap $13M1Y −88.5%Off 52W high −89.4%Vol (1Y) 32966.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 947 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover8.8d |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Earnings (TTM)-$8.0M |
| ROE−109.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−67.3% |
| 1Y−88.5% |
| 3Y−84.7% |
| Since incept. (ann.)−41.5% |
Total return through 2026-07-30 · series begins 2022-10-18. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)32966.8% |
| Ann. volatility (3Y)19058.5% |
| Sharpe (1Y)0.99 |
| Sharpe (3Y)0.58 |
| Max drawdown (1Y)−100.0% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)−2.67 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for ANEB.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2025-12-31 | 2026-02-12 | −$0.05 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$0.05 | — | — | — |
| 2025-03-31 | 2025-05-13 | −$0.04 | — | — | — |
| 2024-12-31 | 2025-02-14 | −$0.09 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
